Background: Nitrogen plasma skin regeneration is a novel device that produces
| INTRODUCTION
Aging is a natural process which occurs throughout the body's systems. One of the most visible signs of aging skin is often shown in the periorbital area. This is usually the first clinical presentation of facial aging.
1 Eyelid skin is the thinnest in the body. passing radiofrequency into nitrogen gas to create plasma: the fourth state of matter, in which electrons are stripped from atoms forming ionized gas. The electrons are then recaptured by positively charged atoms at the same time with energy emitted in a millisecond pulse to the targeted skin, in the form of heat without chromophore dependence. This induces controlled thermal damage in the skin, which results in a production of new collagen and a restructuring of dermal architecture. PSR can be used at various energy settings depending on targeted depths, such as acne scars, skin laxity, photoaging skin, clearance of superficial skin lesions, actinic keratosis, and seborrheic keratosis. Each pulse of plasma energy is released to the treated area in a Gaussian distribution creating an inner zone of thermal damage and an outer zone of thermal modification. [10] [11] [12] [13] [14] [15] Owing to the relatively low thickness of eyelid skin, the low energy of nitrogen plasma may be suitable for eyelid area. The low energy of nitrogen plasma is also safer and has less adverse effects for Thais who have high Fitzpatrick skin type due to the PSR's properties of nonchromophore dependence. However, the treatment with low energy of nitrogen plasma has yet been empirically studied as the treatment for mild-tomoderate periorbital wrinkles in Thai population.
| MATERIALS AND METHODS
This is an experimental, prospective, randomized, controlled evalua- 
| Inclusion criteria
The volunteers aged between 20 and 50 years old with mild-to-moderate periorbital wrinkles based on Lemperle scale (score 0-3).
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| Exclusion criteria
Volunteers who had uncontrolled systemic disease or active skin disease that could interfere with the evaluation of the treated areas, photosensitivity, vitiligo, tendency to develop keloid, pregnancy, and lactation. Volunteers who previously applied topical tretinoin, alpha hydroxy acids, or took oral retinoids within 6 months before the beginning of the study. Volunteers who were treated with ablative laser, other lasers, chemical peeling, botulinum toxin or filler injection, or dermabrasion within six months prior to the study. Volunteers who were unable to follow-up to the study protocol.
| Treatment protocol
Each volunteer was randomized to receive treatment on one side of periorbital wrinkles with three sessions of nitrogen plasma (Neo- Galderma Laboratories) and sunscreen (Spectraban spf 50+; Stiefel Laboratories), and to avoid sun exposure for both two periorbital areas during the study period.
| Outcome evaluation
The clinical evaluation with photographic examination by two independent, blinded dermatologists was determined at baseline, in the third week, the sixth week, and the endpoint evaluation visit at fourteenth week by using Olympus E-3 camera and digital photograph 
| RESULTS
| Demographic data
At over fourteen weeks, eighteen (100%) volunteers completed the study. Sixteen (88.9%) patients were female and two (11.1%) patients were male. The average mean age ± standard deviation (SD) was 39.3 ± 8.4 years. Nine volunteers were classified as Fitzpatrick skin type III, and the others were classified as Fitzpatrick's skintype IV. Seven volunteers had mild periorbital wrinkles, and eleven volunteers had moderate periorbital wrinkles.
| Outcomes
The mean wrinkle score, assessed by two blinded dermatologists,
was not different at baseline between the two groups. In the treatment group, the mean wrinkle score at baseline was 2.5 ± 0.7 and changed to 1.9 ± 0.8 at 14-week visit. But in the control group, the mean wrinkle score at baseline was 2.5 ± 0.7 and changed to 2.3 ± 0.7 in the 14-week visit. The mean wrinkle score decreased from baseline in the treatment group more than the control group with statistically significant at 14-week visit (P = 0.004) (Figure 2 ).
The mean skin wrinkle (SEw), measured by the Visioscan® VC98,
showed no difference at baseline between two groups. In the treatment group, the mean SEw at baseline was 45.5 ± 4.6 and changed to 39.1 ± 3 at 14-week visit. But in the control group, the mean SEw at baseline was 45.4 ± 3.4 and changed to 43 ± 2.5 in the 14-week visit. The mean SEw showed more improvement in the treatment group than control group with statistically significant starting from 3-week visit through the 14-week visit (P < 0.05) (Figure 3 ).
The mean melanin index, measured by the Mexameter® MX 18,
showed no difference at baseline between two groups. In the treatment group, the mean melanin index at baseline was 504 ± 16.7 and changed to 481.8 ± 13.2 at 14-week visit. But in the control group, the mean melanin index at baseline was 504.5 ± 17.3 and changed to 495.4 ± 14.3 in the 14-week visit. The mean melanin index showed more improvement in the treatment group than a control group with statistically significant starting from the 3-week visit through the 14-week visit (P < 0.05) (Figure 4 ). This study also showed significantly higher satisfaction scores among volunteers in the treatment group than the control group (P < 0.001). The clinical improvement picture is shown in Figure 5 .
The common short-term adverse effects of the nitrogen plasma groups included erythema, scaling, temporary hyperpigmentation,
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| 165 pruritus, and dryness. The number and duration of these adverse effects are shown in Table 1 . The shortest duration among all the adverse effect was erythema (12 hours), and the longest duration was hyperpigmentation and desquamation (48 hours). All the adverse effects were mild and resolved without permanent skin change or scarring. The volunteers rated the pain scores at a mild level of severity (1-3 points).
| DISCUSSION
Periorbital wrinkle is a common aesthetic problem. The plasma skin regeneration can be used to treat this condition by providing the energy to create thermal effect on the skin. Most of the previous PSR studies focus on medium and high energy treatment. There was a study which was done by Bernstein 17 used very low energy, using 0.5 J, three times at a 3-week interval full-face treatment in 12 volunteers in cutaneous photodamaged skin, the result showed that there was minimum of 25% reduction in physician wrinkle score at 1 month with increased improvement at 3 months, improvement in textural irregularity, and 40%-80% patient rate overall improvement.
This study provides supportive evidence to the efficacy of the very low energy treatment for cutaneous photodamage. Therefore, the authors decided to conduct an experimental study for the treatment of mild-to-moderate periorbital wrinkles with low-energy plasma in
Thais who have higher Fitzpatrick's skin type.
From our study, there was an improvement in the appearances of periorbital wrinkles at 3-week visit after the treatment measuring by melanin index and SEw score by Visioscan® VC 98. However, clinical improvement was seen at 14-week visit after treatment. Our study also showed that the adverse effects of the nitrogen plasma were relatively mild and safe for general practice. These could be explained by nonchromophore properties of PSR.
Our study was the first clinical trial using multiple treatments with lower energy of PSR for mild-to-moderate periorbital wrinkles in study volunteers with higher Fitzpatrick's skin type IV. The methodology is robust as the study is randomized, double-blinded, controlled study with well-defined methodology.
Regarding the limitations, our enrolled patients were only restricted to those with mild-to-moderate periorbital wrinkles. Our F I G U R E 3 To demonstrate mean wrinkle (SEw) at baseline, 3-week, 6-week, 14-week visit of nitrogen plasma group and control group.
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In conclusion, our study showed that nitrogen plasma is highly effective and relatively safe for the treatment of mild-to-moderate periorbital wrinkles and darkening.
